Insider filing · INCY
Herve Hoppenot
Director
profile →
Incyte Corporation
INCY · Healthcare · 38 filings in 24 months
ticker →
Herve Hoppenot sold $19.8M of Incyte (INCY)
Executed Nov 10 2025, disclosed Nov 12 2025, 2 days later.
Value, as filed
$19.8M
187,500 sh × $105.46
Executed
Nov 10 2025
the trade date, as filed
Disclosed
Nov 12 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
HHHerve Hoppenot (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Incyte Corporation (INCY). The largest single filing was $19.8M of INCY (187,500 sh × $105.46, as filed), executed Nov 10 2025.
The name
INCYHealthcare · Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→